BLRX Stock Price
BioLineRx Ltd.
BLRX stock price is $2.14 (+3.13% on the day), giving BioLineRx Ltd. a market cap of $10.33M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
BLRX Stock Overview
- Price
- $2.14
- Previous close
- $2.08
- Open
- $2.03
- Market cap
- $10.33M
- P/E ratio
- -1.1
- 52-week range
- $2.15 - $4.14
- 1-year price target
- $22.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 41
About BioLineRx Ltd.
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BLRX | $2.14 | +3.1% | 24.79K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |